Retrieve available abstracts of 18 articles: HTML format
Single Articles
July 2025
CASTILLEJO BECERRA CM, Crowson CS, Langenfeld HE, Tajfirouz D, et al Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis.
Am J Ophthalmol. 2025;275:47-51. PubMedAbstract available
May 2025
CHOU HD, Heimann H, Damato BE, Hussain RN, et al Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence,
Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery.
Am J Ophthalmol. 2025 May 31:S0002-9394(25)00278. PubMedAbstract available
March 2025
MUKIT FA, Terfloth N, Kim IK, Wu F, et al Malignant transformation of ocular melanocytoma to uveal melanoma: a
clinicopathologic review of three novel unsuspected cases of a likely
under-recognized phenomenon, with review of the literature and molecular genetic
data.
Am J Ophthalmol. 2025 Mar 31:S0002-9394(25)00164. PubMedAbstract available
WANG C, Gu J Giant Conjunctival Melanoma.
Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00156. PubMed
NISSEN K, Kiilgaard JF, Fili M, Seregard S, et al Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A
Tri-National Study.
Am J Ophthalmol. 2025 Mar 5:S0002-9394(25)00115. PubMedAbstract available
February 2025
JANMOHAMED IK, Salam MAU, Jamall O, Elgharably M, et al Faricimab-Associated Intraocular Inflammation with Features of Herpes Simplex
Virus.
Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00096. PubMedAbstract available
December 2024
CAPPELLI L, Khan MM, Shields CL, Lally SE, et al Favorable outcomes of patients with high-risk uveal melanoma treated with a novel
LINAC-based frameless fractionated stereotactic radiosurgery.
Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00564. PubMedAbstract available
October 2024
TIAN H, Shi H, Chen J, Zhu T, et al Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value.
Am J Ophthalmol. 2024 Oct 16:S0002-9394(24)00479. PubMedAbstract available
LAI WY, Demer JL Cutaneous Lower Eyelid Retractor Release Averts Lower Lid Malposition After
Inferior Rectus Muscle Recession.
Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00460. PubMedAbstract available
ZHANG MG, Gallo RA, Tan CH, Camacho M, et al Single-cell RNA profiling of ocular adnexal sebaceous carcinoma reveals a complex
tumor microenvironment and identifies new biomarkers.
Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00471. PubMedAbstract available
BARBARA R, Abdelaal AM, Levy R, Nagy A, et al Pediatric Eyelid Cutaneous Horns: A Case Series and Literature Review.
Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00465. PubMedAbstract available
September 2024
RAMING K, Pfau M, Herrmann P, Holz FG, et al Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum
- Age of Onset, Treatment Frequency, and Visual Outcome.
Am J Ophthalmol. 2024;265:127-136. PubMedAbstract available
August 2024
LEE MY, Han K, Min KH, Yu DS, et al Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type
2 Diabetes Mellitus: A Nationwide Cohort Study.
Am J Ophthalmol. 2024 Aug 30:S0002-9394(24)00395. PubMedAbstract available
VEMPULURU VS, Tanna V, Luthra A, Kaliki S, et al Eyelid/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis based on 8(th)
Edition American Joint Cancer Committee Classification.
Am J Ophthalmol. 2024 Aug 3:S0002-9394(24)00350. PubMedAbstract available
July 2024
JUNG H, Kim S, Lee CS, Byeon SH, et al Real-world incidence of incident noninfectious uveitis in patients treated with
BRAF inhibitors: a nationwide clinical cohort study.
Am J Ophthalmol. 2024 Jul 6:S0002-9394(24)00300. PubMedAbstract available
May 2024
KOJIMA M, Mieno H, Ueta M, Nakata M, et al Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal
Necrolysis: A National Survey in Japan.
Am J Ophthalmol. 2024 May 23:S0002-9394(24)00212. PubMedAbstract available
WYLEGALA A, Pajak J, Wylegala E Bilateral Corneal and Conjunctival Melanosis.
Am J Ophthalmol. 2024 May 17:S0002-9394(24)00206. PubMed
November 2023
CHOUDHRY HS, Patel AM, Nguyen HN, Kaleem MA, et al Significance of Social Determinants of Health in Tumor Presentation, Hospital
Readmission, and Overall Survival in Ocular Oncology.
Am J Ophthalmol. 2023 Nov 11:S0002-9394(23)00455. PubMedAbstract available